BRCA2 and ovarian cancer: However, it is increasingly appreciated that polygenic as well as monogenic risk may affect cancer incidence and its progression.3 Polygenic risk reflets the cumulative influence of many different sources of genetic variation on disease risk, rather than the influence only of rare pathogenic variants in single genes, eg, the BRCA1/BRCA2 genes for breast and ovarian cancer.4